4.8 Article

Structural Mass Spectrometry in Protein Therapeutics Discovery

Journal

ANALYTICAL CHEMISTRY
Volume 82, Issue 17, Pages 7083-7089

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ac101575d

Keywords

-

Ask authors/readers for more resources

The protein therapeutics market is one of the highest growing segments of the pharmaceutical industry with an estimated global market value of $77 billion by 2011 (Global Protein Therapeutics Market report by RNCOS: Delhi, India, 2009). This growth has been fueled by several advantages that protein drugs can offer such as higher specificity, reduced side effects, and faster development time compared to small molecule drugs. Major pharmaceutical companies are strategically shifting gears toward protein therapeutics and gradually increasing the biologics portion of their pipelines. Consequently, in the present pharmaceutical industry, there is a rapid growth in the number and types of protein structural mass spectrometry analyses, particularly during the discovery phase where an abundance of new drug candidates are being investigated. This perspective article discusses the role of protein structural mass spectrometry during the discovery of protein therapeutics with focus on recombinant protein production quality control and structural biology applications. The current challenges in technologies associated with this field and the analytical prospects for the future direction will be also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemical Research Methods

Hydrogen/deuterium exchange mass spectrometry applied to IL-23 interaction characteristics: potential impact for therapeutics

Roxana E. Iacob, Stanley R. Krystek, Richard Y-C Huang, Hui Wei, Li Tao, Zheng Lin, Paul E. Morin, Michael L. Doyle, Adrienne A. Tymiak, John R. Engen, Guodong Chen

EXPERT REVIEW OF PROTEOMICS (2015)

Article Chemistry, Medicinal

Comparison of Ensemble and Single Molecule Methods for Particle Characterization and Binding Analysis of a PEGylated Single-Domain Antibody

Lumelle A. Schneeweis, Linda Obenauer-Kutner, Parminder Kaur, Aaron P. Yamniuk, James Tamura, Neil Jaffe, Brian W. O'Mara, Stuart Lindsay, Michael Doyle, James Bryson

JOURNAL OF PHARMACEUTICAL SCIENCES (2015)

Article Biochemical Research Methods

The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex

Vidhyashankar Ramamurthy, Aaron P. Yamniuk, Eric J. Lawrence, Wei Yong, Lumelle A. Schneeweis, Lin Cheng, Melissa Murdock, Martin J. Corbett, Michael L. Doyle, Steven Sheriff

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2015)

Article Biochemical Research Methods

Assessing compound binding to the Eg5 motor domain using a thermal shift assay

Patricia A. McDonnell, Joseph Yanchunas, John A. Newitt, Li Tao, Susan E. Kiefer, Marie Ortega, Stephanie Kut, Neil Burford, Valentina Goldfarb, Gerald J. Duke, Henry Shen, William Metzler, Michael Doyle, Zhong Chen, Christine Tarby, Robert Borzilleri, Wayne Vaccaro, Marco Gottardis, Songfeng Lu, Donald Crews, Kyoung Kim, Louis Lombardo, Deborah L. Roussell

ANALYTICAL BIOCHEMISTRY (2009)

Article Chemistry, Medicinal

Application of a kosmotrope-based solubility assay to multiple protein therapeutic classes indicates broad use as a high-throughput screen for protein therapeutic aggregation propensity

Aaron P. Yamniuk, Noah Ditto, Mehul Patel, Jun Dai, Preeti Sejwal, Paul Stetsko, Michael L. Doyle

JOURNAL OF PHARMACEUTICAL SCIENCES (2013)

Article Pharmacology & Pharmacy

Reversible and pH-dependent weak drug-excipient binding does not affect oral bioavailability of high dose drugs

Ajit S. Narang, Aaron P. Yamniuk, Limin Zhang, S. Nilgun Comezoglu, Dilbir S. Bindra, Sailesh Varia, Michael L. Doyle, Sherif Badawy

JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)

Article Biochemical Research Methods

Time-resolved limited proteolysis of mitogen-activated protein kinase-activated protein kinase-2 determined by LC/MS only

Li Tao, Susan E. Kiefer, Dianlin Xie, James W. Bryson, Stanley A. Hefta, Michael L. Doyle

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2008)

Article Biochemical Research Methods

The Influence of Adnectin Binding on the Extracellular Domain of Epidermal Growth Factor Receptor

Roxana E. Iacob, Guodong Chen, Joomi Ahn, Stephane Houel, Hui Wei, Jingjie Mo, Li Tao, Daniel Cohen, Dianlin Xie, Zheng Lin, Paul E. Morin, Michael L. Doyle, Adrienne A. Tymiak, John R. Engen

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2014)

Article Medicine, Research & Experimental

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

Stuart L. Emanuel, Linda J. Engle, Ginger Chao, Rong-Rong Zhu, Carolyn Cao, Zheng Lin, Aaron Yamniuk, Jennifer Hosbach, Jennifer Brown, Elizabeth Fitzpatrick, Jochem Gokemeijer, Paul Morin, Brent Morse, Irvith M. Carvajal, David Fabrizio, Martin C. Wright, Ruchira Das Gupta, Michael Gosselin, Daniel Cataldo, Rolf P. Ryseck, Michael L. Doyle, Tai W. Wong, Raymond T. Camphausen, Sharon T. Cload, H. Nicholas Marsh, Marco M. Gottardis, Eric S. Furfine

Article Biochemistry & Molecular Biology

Structural and functional characterization of CFE88: Evidence that a conserved and essential bacterial protein is a methyltransferase

KL Constantine, SR Krystek, MD Healy, ML Doyle, NO Siemers, J Thanassi, N Yan, DL Xie, V Goldfarb, J Yanchunas, L Tao, BA Dougherty, BT Farmer

PROTEIN SCIENCE (2005)

Article Immunology

Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus

Jenny H. Xie, Yifan Zhang, Martine Loubeau, Paul Mangan, Elizabeth Heimrich, Christian Tovar, Xiadi Zhou, Priyanka Madia, Michael Doyle, Shailesh Dudhgaonkar, Anjuman Rudra, Siva Subramani, James Young, Luisa Salter-Cid, Thomas R. Malek, Mary Struthers

Summary: Fusion protein of mouse IL-2 and CD25 shows promising therapeutic effects in treating SLE and diabetes without significant side effects.

JOURNAL OF IMMUNOLOGY (2021)

Article Microbiology

Molecular basis for increased susceptibility of isolates with atazanavir resistance-conferring substitution I50L to other protease inhibitors

J Yanchunas, DR Langley, L Tao, RE Rose, J Friborg, RJ Colonno, ML Doyle

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Biochemistry & Molecular Biology

Decrypting the biochemical function of an essential gene from Streptococcus pneumoniae using ThermoFluor® technology

TE Carver, B Bordeau, MD Cummings, EC Petrella, MJ Pucci, LE Zawadzke, BA Dougherty, JA Tredup, JW Bryson, J Yanchunas, ML Doyle, MR Witmer, MI Nelen, RL DesJarlais, EP Jaeger, H Devine, ED Asel, BA Springer, R Bone, FR Salemme, MJ Todd

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Selective binding and oligomerization of the murine granulocyte colony-stimulating factor receptor by a low molecular weight, nonpeptidyl ligand

ML Doyle, SS Tian, SG Miller, L Kessler, AE Baker, MR Brigham-Burke, SB Dillon, KJ Duffy, RM Keenan, R Lehr, J Rosen, LA Schneeweis, J Trill, PR Young, JI Luengo, P Lamb

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

No Data Available